Correlation of glymphatic system abnormalities with Parkinson's disease progression: a clinical study based on non-invasive fMRI
- PMID: 37755462
- DOI: 10.1007/s00415-023-12004-6
Correlation of glymphatic system abnormalities with Parkinson's disease progression: a clinical study based on non-invasive fMRI
Abstract
Background: The glymphatic system is reportedly involved in Parkinson's disease (PD). Based on previous studies, we aimed to confirm the correlation between the glymphatic system and PD progression by combining two imaging parameters, diffusion tensor image analysis along the perivascular space (DTI-ALPS), and enlarged perivascular spaces (EPVS).
Methods: Fifty-one PD patients and fifty healthy control (HC) were included. Based on the Hoehn-Yahr scale, the PD group was divided into early-stage and medium-to late-stage. All PD patients were scored using the Unified PD Rating Scale (UPDRS). We assessed the DTI-ALPS indices in the bilateral hemispheres and EPVS numbers in bilateral centrum semiovale (CSO), basal ganglia (BG), and midbrain.
Results: The DTI-ALPS indices were significantly lower bilaterally in PD patients than in the HC group, and EPVS numbers in any of the bilateral CSO, BG, and midbrain were significantly higher, especially for the medium- to late-stage group and the BG region. In PD patients, the DTI-ALPS index was significantly negatively correlated with age, while the BG-EPVS numbers were significantly positively correlated with age. Furthermore, the DTI-ALPS index was negatively correlated with UPDRS II and III scores, while the BG-EPVS numbers were positively correlated with UPDRS II and III scores. Similarly, the correlation was more pronounced in the medium- to late-stage group.
Conclusion: The DTI-ALPS index and EPVS numbers (especially in the BG region) are closely related to age and PD progression and can serve as non-invasive assessments for glymphatic dysfunction and its interventions in clinical studies.
Keywords: Diffusion tensor image analysis along the perivascular space; Enlarged perivascular spaces; Glymphatic system; Parkinson’s disease.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Noninvasive neuroimaging provides evidence for deterioration of the glymphatic system in Parkinson's disease relative to essential tremor.Parkinsonism Relat Disord. 2023 Feb;107:105254. doi: 10.1016/j.parkreldis.2022.105254. Epub 2022 Dec 24. Parkinsonism Relat Disord. 2023. PMID: 36584484
-
Glymphatic function from diffusion-tensor MRI to predict conversion from mild cognitive impairment to dementia in Parkinson's disease.J Neurol. 2024 Aug;271(8):5598-5609. doi: 10.1007/s00415-024-12525-8. Epub 2024 Jun 24. J Neurol. 2024. PMID: 38913186 Free PMC article.
-
Early detection of dopaminergic dysfunction and glymphatic system impairment in Parkinson's disease.Parkinsonism Relat Disord. 2024 Oct;127:107089. doi: 10.1016/j.parkreldis.2024.107089. Epub 2024 Aug 2. Parkinsonism Relat Disord. 2024. PMID: 39106761
-
Diffusion Tensor Imaging Along the Perivascular Space Is a Promising Imaging Method in Parkinson's Disease: A Systematic Review and Meta-Analysis Study.CNS Neurosci Ther. 2025 May;31(5):e70434. doi: 10.1111/cns.70434. CNS Neurosci Ther. 2025. PMID: 40376934 Free PMC article. Review.
-
Factors associated with the location of perivascular space enlargement in middle-aged individuals undergoing brain screening in Japan.Clin Neurol Neurosurg. 2022 Dec;223:107497. doi: 10.1016/j.clineuro.2022.107497. Epub 2022 Nov 2. Clin Neurol Neurosurg. 2022. PMID: 36356441 Review.
Cited by
-
Diffusion tensor image analysis along the perivascular space and quantitative susceptibility mapping in the diagnosis and severity assessment of Parkinson's disease.Quant Imaging Med Surg. 2025 Feb 1;15(2):1411-1424. doi: 10.21037/qims-24-1605. Epub 2025 Jan 22. Quant Imaging Med Surg. 2025. PMID: 39995711 Free PMC article.
-
Glymphatic and neurofluidic dysfunction in classical trigeminal neuralgia: a multimodal MRI study of brain-CSF functional and structural dynamics.BMC Med Imaging. 2025 Jul 1;25(1):222. doi: 10.1186/s12880-025-01801-2. BMC Med Imaging. 2025. PMID: 40596979 Free PMC article.
-
Clinical and brain volumetric correlates of decreased DTI-ALPS, suggestive of local glymphatic dysfunction, in iRBD.NPJ Parkinsons Dis. 2025 Apr 23;11(1):87. doi: 10.1038/s41531-025-00942-z. NPJ Parkinsons Dis. 2025. PMID: 40268930 Free PMC article.
-
Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.J Neurol. 2025 Feb 11;272(3):196. doi: 10.1007/s00415-025-12944-1. J Neurol. 2025. PMID: 39932513
-
Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease.Eur J Neurol. 2024 Dec;31(12):e16521. doi: 10.1111/ene.16521. Epub 2024 Oct 19. Eur J Neurol. 2024. PMID: 39425566 Free PMC article.
References
-
- GBD (2016) Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459–480. https://doi.org/10.1016/s1474-4422(18)30499-x - DOI
-
- Keir LHM, Breen DP (2020) New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson’s disease. J Neurol 267:288–294. https://doi.org/10.1007/s00415-019-09651-z - DOI - PubMed
-
- Atik A, Stewart T, Zhang J (2016) Alpha-synuclein as a biomarker for Parkinson’s disease. Brain Pathol 26:410–418. https://doi.org/10.1111/bpa.12370 - DOI - PubMed - PMC
-
- Mehra S, Sahay S, Maji SK (2019) α-Synuclein misfolding and aggregation: implications in Parkinson’s disease pathogenesis. Biochim Biophys Acta Proteins Proteom 1867:890–908. https://doi.org/10.1016/j.bbapap.2019.03.001 - DOI - PubMed
-
- Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 20:385–397. https://doi.org/10.1016/s1474-4422(21)00030-2 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical